Patients with early rheumatoid arthritis (RA) who received certolizumab pegol (Cimzia) plus methotrexate for a year had improved outcomes during the following year -- after stopping the biologic -- compared with those who received methotrexate alone for the 2 years, Japanese researchers reported.
https://www.medpagetoday.com/Rheumatology/Arthritis/65731?xid=nl_mpt_Weekly_Education_2017-06-07&eun=g5883165d1r
No comments:
Post a Comment